Cancer Research UK

EU Legislative Interests

EU-UK relations (EU-UK Trade & Cooperation Agreement); UK Data Adequacy decisions; EU Clinical Trial Regulation, Horizon Europe, tobacco control (Tobacco Taxation Directive; Framework Convention on Tobacco Control including Article 5.3) and other public health potentially including obesity in future; EU Cancer Plan in general including European Health Data Space, EU Orphan & Paediatric Medicines Regulations, EU Pharmaceutical Legislation. Anything else regarding life sciences e.g. biotech legislation.

Communication Activities

Attend events aimed at the cancer, health and science policy communities at which EU officials can be present, including in the UK. Participation in EU-facing coalition/org meetings and activities at which EU officials can be present (e.g. MEPs Against Cancer; the European Cancer Organisation's European Cancer Summit 2025). In the past, CRUK has held a meetings programme including EU officials and elected politicians, and we intend to do so again during 2025-26, as appropriate to the UK's new relationship with the EU. Potentially CRUK/joint articles for European media.

Interests Represented

Does not represent commercial interests

Member Of

Cancer Research Horizons (CRH) is the innovation arm of Cancer Research UK (a wholly owned subsidiary). CRH operates at the interface between research and industry to accelerate the translation of innovative science into treatments and diagnostics for people with cancer around the world. CRH partners in several ways, including through licensing, start-ups, collaborations and forming drug discovery alliances. Partners include academic institutions, pharmaceutical and biotechnology companies, investors and other medical research such as the Dutch and Norwegian Cancer Societies. https://www.cancerresearchhorizons.com/about-us We are a paying member of or work jointly with many associations/networks etc, including the Cancer Grand Challenges, European Organisation for Research and Treatment of Cancer (EORTC), International Cancer Benchmarking Partnership, Cancer Prevention Europe (CPE - led by IARC), Smoke Free Partnership (SFP), Union for International Cancer Control (UICC), Federation of European Academies of Medicine (FEAM), Association of European Cancer Leagues (ECL), European Cancer Organisation (ECO), Global Alliance for Tobacco Control (GATC), NCD Alliance (NCDA), International Alliance for Cancer Early Detection (ACED), G7 Cancer initiative, International Cancer Research Partnership (ICRP). We would be happy to expand if needed.

Organisation Members

We provide international funding for researchers in over 20 countries and work with over 200 partners across the globe- including the US, French and Dutch government-funded cancer institutes and NGOs (Cancer Grand Challenges). We have relationships and policy partnerships with other cancer societies around the world including across the EU. We would be happy to expand if needed. Cancer Research Horizons joined the PRIME-ROSE project in 2023, which is funded by Horizon Europe https://www.cancerresearchhorizons.com/news/cancer-research-uk-joins-european-precision-cancer-medicine-trial-consortium It is very likely that individual CRUK-funded researchers (some in CRUK-funded institutes) have now applied successfully for European Research Council grants for Horizon Europe collaborations.

Additional Information

For a list of benefactors, major supporters, major trusts and foundations, corporate partners and other donation information, please see CRUK's annual report and accounts https://www.cancerresearchuk.org/about-us/our-organisation/how-we-spend-your-money In 2024/25, our expenditure was: • £419m committed to research including for future years (we spent £403m, which includes money committed in previous years) • £34m on cancer information and influencing activity • £130m costs of generating funds • £132m on trading (including shops and online marketplaces)